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ABSTRACT
Objectives: In India, 69.1 million are diabetics as of 2015 compared to 18 million in 1995. Pan India prevalence study in diabetics carried out at 
194 centers by All India Ophthalmological Society reported the prevalence of diabetic retinopathy (DR) among diabetics as 21.8%. DR is of two types, 
non-proliferative diabetic retinopathy (NPDR), and proliferative diabetic retinopathy (PDR). The severity of NPDR depends on microaneurysms, 
hemorrhages, cotton wool spots, and beading of veins and can progress to PDR. Inherit characteristic of PDR is neovascularization. The aim of this 
observational prevalence study is to study the prevalence of diabetic retinopathy in Type 2 diabetic patients attending diabetic clinic and to study the 
distribution of diabetic retinopathy with respect to age, sex, and duration of disease in a tertiary care hospital in southern India.
Methods: This is a retrospective observational study. Age above 20 years and patients diagnosed with Type 2 diabetes mellitus (DM) and examined by 
the ophthalmologist were included and others excluded. Data documented were analyzed using statistical software SPSS version 16.
Results: About 52.07% of patients with Type 2 DM for more than 10 years had diabetic retinopathy and 13.07 % of patients with Type 2 DM for more 
than 5 years have diabetic retinopathy.
Conclusion: India being the diabetic capital of the world and DR being the most common cause for visual impairment and blindness and it becomes 
empirical to assess the factors for its rising prevalence, which will significantly contribute in reducing the progression of DR.
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INTRODUCTION
Diabetes mellitus (DM) has exemplified its presence globally. In 
India, 69.1 million are diabetics as of 2015 compared to 18 million 
in 1995 [1,2]. At this rate, crossing one billion as estimated by the 
International Diabetes Federation Association and World health 
organization seems obvious [1]. Pan India studies on the prevalence of 
Diabetic retinopathy (DR) are limited, few initial studies, such as The 
Chennai Urban Rural Epidemiology Study and Arvind comprehensive 
eye study in rural population, concluded the prevalence of DR as 17.8% 
and 10.8% in diabetics, respectively [3,4]. Pan India prevalence study 
in diabetics carried out at 194 centers by All India Ophthalmological 
Society (AIOS) reported the prevalence of DR among diabetics as 
21.8% [5]. The prevalence of DR at the time of diagnosis of Type 2 DM is 
7.3 as observed in a study at a tertiary care hospital [6].
DR is a common microvascular complication, an important 
complication among adults and elderly. DR is of two types, non-
proliferative diabetic retinopathy (NPDR) and proliferative diabetic 
retinopathy (PDR). Severity of NPDR depends on microaneurysms, 
hemorrhages, cotton wool spots, and beading of veins and can 
progress to PDR. Inherit characteristic of PDR is neovascularization. 
Its either PDR or diabetic maculopathy that is responsible for vision 
loss. Chronic hyperglycemia inflicts profoundly in development 
and progression of DR by stimulating multiple mechanisms such 
as polyol pathway, enzymatic glycation, protein kinase C activation, 
hemodynamic changes, and renin angiotensin aldosterone pathway [7] 
and Type 2 DM accounts for more than 90% of the diabetic population 
worldwide [8].
The aim of this observational prevalence study is to study the prevalence 
of DR in Type 2 Diabetic patients attending diabetic clinic and to study 
the distribution of DR with respect to age, sex, and duration of disease 
in a tertiary care hospital in southern India.
METHODS
Study design
This is a retrospective observational study. Institutional ethical 
clearance was obtained.
Study duration
April 2010 till October 2010.
Sampling method
Information taken from previous studies.
Inclusion criteria
Age above 20 years. All patients diagnosed with Type 2 DM and were 
examined by the ophthalmologist.
Exclusion criteria
All patients diagnosed of Type 2 DM and did not undergo 
ophthalmologist examination.
Data were collected and documented from medical records of patients 
fulfilling the inclusion criteria. Findings of ophthalmology examination 
as recorded by ophthalmologist were also documented:
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4. Diabetic maculopathy or complicated with vitreous hemorrhage or 
retinal detachment.
Statistical analysis
Data documented were analyzed using statistical software SPSS 
version 16.
RESULTS
In Toto, 356 medical records of patients visiting the specialty diabetic 
clinic were viewed. 63 were excluded as they did not undergo 
ophthalmology examination (Table 1 and Fig. 1) depict the prevalence of 
DR unadjusted to age and sex. Out of 293 patients, 74.5% (219) of them 
had no DR, 7.5% (22) have non-proliferative retinopathy, 13.5% (40) 
have proliferative retinopathy, and 4% (12) have complicated 
retinopathy. Total 185 males had diabetes out of which, 74.5% (138) 
had no retinopathy, 7.0% (13) had non-proliferative retinopathy, 
13.5% (25) had proliferative retinopathy, and 4.8% (9) had complicated 
retinopathy and among 108 diabetic females, 75% (81) had no DR, 
8.33% (15) had proliferative DR, 13.8% (9) had non-proliferative and 
2.7% (3) had complicated retinopathy (Table 2 and Fig. 2). Among 
12 patients with complicated DR, 7 of them had retinal detachment, 
4 of them had severe maculopathy with blindness and 1 had vitreous 
hemorrhage.
Agewise distribution depicted in (Fig. 3), 111 diabetics were above 
60 years, 107 diabetics were in between 50-60 years, and 75 diabetics 
were below 50 years duration of disease. Out of 293 patients, 112 had 
diabetes for more than 10 years and 130 patients had DM for more than 
5 years. 59 and 17 patient out of 112 and 130 patients respectively had 
DR. Therefore, the 52.07% of patients with Type 2 DM for more than 
10 years had DR and 13.07 % of patients with Type 2 DM for more than 
5 years have DR.
DISCUSSION
The prevalence of diabetes and DR is continuously increasing. 
According to studies done in South Indian urban population, the 
prevalence of DR ranges from 12% to 22.4% [6,9,10]. The prevalence 
of DR among other Asian countries such as Singapore and Japan is less 
compared to India possibly due to protective factors in these population 
or shorter duration of disease [2]. According to this study, the overall 
prevalence of DR in this diabetic population is 25%, which correlates 
with 23.8% and 22% prevalence of DR reported by National Urban 
Diabetic Society and AIOS DR eye screening study 2014 [5,11]. Here, 
the population was not defined on the basis of socioeconomic status; 
therefore, the prevalence among urban and rural population cannot 
be determined. The prevalence of diabetes is more among the patients 
with age >60 years (38%) compared to age between 50-60 years and 
less than 50 years. From 40 to 80 years, the prevalence of DR increases, 
then tapers slightly probably due to decreased life expectancy due to 
diabetes and other comorbidities.
In this study, the prevalence of DR is more among male compared to 
females; the reason for preponderance of DR irrespective of severity in 
males is unknown but similar prevalence of DR more in males is observed 
in studies such as The Chennai urban rural study, Andhra Pradesh eye 
disease study, and the United Kingdom prospective diabetes study [2]. 
One reason could be as males are genetically predisposed to non-
communicable health disorders such as atherosclerosis, myocardial 
infarction, and cancer. The prevalence of DR was more among those 
who had diabetes for 10 years or more compared to those who had 
duration of diabetes for 5 years or less correlates with the AIOS study 
wherein of all the 6418 patients screened and it was observed those 
with more than 5 years of diabetes had 35% prevalence compared to 
those who had diabetes less than 5 years and 6 months [5]. Duration 
of the diabetes is a significant predictor for the prevalence of DR, risk 
Table 1: Prevalence of diabetic retinopathy in study population
Ophthalmoscopy 
examination
Total number of diabetics 
retinopathy (%)
No retinopathy 219 (74.8)
Non-proliferative retinopathy 22 (7.5)
Proliferative retinopathy 40 (13.7)
Complicated 12 (4)
Table 2: Gender wise distribution of diabetic retinopathy
Ophthalmoscopy examination Male (%) Female (%)
No retinopathy 138 (74.5) 81 (75)
NPDR 13 (7.0) 9 (8.33)
PDR 25 (13.51) 15 (13.8)
Complicated 9 (4.8) 3 (2.7)
Total 185 108
NPDR: Non-proliferative diabetic retinopathy, PDR: Proliferative diabetic 
retinopathy
Fig. 1: Prevalence of retinopathy
Fig. 2: Gender wise distribution of diabetic retinopathy
Fig. 3: Agewise distribution of diabetic patients
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increases with the increase in duration of disease. There are many 
risk factors that contribute to the development of retinopathy. The 
prevalence of diabetes and DR is less in rural population compared 
to urban, educated and affluent population as observed in one study 
carried out in rural population of Chennai [12]. The reason being 
reduced physical energy expenditure as a result of sedentary lifestyle 
and unhealthy dietary practices hence socioeconomic status plays 
a significant role in influencing the development of diabetes and its 
complications [12]. Furthermore, the lack of education, awareness or 
instructions regarding complications of diabetes or routine screening 
add to the burden of disease. The prevalence study among inpatients 
carried out by Jessica et al. it was observed that transportation, 
disability, affordability, no time, associated renal impairment, etc., 
were some of the factors along with age and duration of disease [13]. 
Limitations of this study were that the population were not further 
categorized as per socioeconomic status, education, comorbidities, 
etc., however the strength of this study is that reinforced the increasing 
prevalence of DR at a tertiary care hospital.
CONCLUSION
There are many prevalence studies in India signifying the prevalence 
of diabetes and DR among both urban and rural population and also 
risk factors that influence strongly the development of DR. Prevalence 
studies do have significance apart from providing health-care 
professionals a crucial information regarding the disease burden; they 
also implicate the challenges to be conquered in diagnosis, therapy, 
prognosis, and educating the patient. Screening and population-based 
studies in hospital setting can provide additional information on how 
factors like existing comorbidities influence DR. India being the diabetic 
capital of the world and DR being the most common cause for visual 
impairment and blindness; it becomes empirical to assess the factors 
for its rising prevalence, which will significantly contribute in reducing 
the progression of DR.
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